Renlo Health review
Flat price, backend named
Names its provider group, its pharmacy and its 503A basis — and charges one flat monthly price at every dose.
Our verdict
Renlo Health does two things well that rarely appear together. It prices flat and monthly — $199 for semaglutide, $269 for tirzepatide, $179 for NAD⁺ — with no membership, consultation or cancellation fee, so the advertised figure is the figure you pay in month one. And its compliance page names the parts most services leave abstract: the provider group is Arora Health & Aesthetics, LLC, the pharmacy is VialsRX, the compounding basis is 503A. Two things deserve scrutiny rather than credit. The struck-through $299 and $399 anchors are never explained, and the dose-escalation chart beside them is labeled illustrative of the category rather than sourced to a named competitor — which makes it a chart about nobody.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 telehealth
- Access
- Semaglutide $199/mo flat, tirzepatide $269; no membership or consult fee; Arora Health group, VialsRX
- Medications
- Compounded semaglutide · Compounded tirzepatide
- Insurance
- Cash-pay, no insurance
- Visit
- Quiz intake / Async intake
- Availability
- All 50 states (stated)
- LegitScript
- Claimed by provider
- Updated
- September 2026
Sponsored alternative
Enhance MD
Lab-guided treatment under ongoing physician oversight
Check Enhance MD availability →What it is
Renlo Health LLC, a telehealth platform coordinating access to independent licensed providers and a partner pharmacy network, selling compounded GLP-1 medication and a two-product longevity line. It is explicit that it does not itself deliver clinical care. Its LegitScript seal id resolves against the issuer, and it publishes a four-month money-back guarantee conditioned on following the plan.
How it works
Asynchronous, through an online visit. ★ Its compliance page is unusually complete about who actually does what: the provider group is named as Arora Health & Aesthetics, LLC, serving all 50 states; the partner pharmacy is named as VialsRX; and compounding is stated to be under Section 503A. ⚠ Arora Health & Aesthetics is the same medical group already behind Solaya MD, The Edit and Trellis Vitality on this site — four brands over one provider group — and VialsRX is the same pharmacy Idgie Health names. Renlo's catalog and prices are its own, so this is a shared back end rather than a shared storefront, but a reader comparing Renlo with those services is not comparing independent clinical operations.
Pricing transparency
Flat and monthly, with the qualifiers removed rather than buried. Compounded semaglutide is $199/month and tirzepatide $269/month, the same at every dose; NAD⁺ injection is $179/month and glutathione $129/month on the same terms. The site states no membership fee, no consultation fee, monthly billing, cancel any time with no fee, and free shipping. A $50 first-order discount code runs sitewide. ⚠ Each price sits beside a struck-through anchor — $299 for semaglutide, $399 for tirzepatide — that is never explained as a former price, a list price or a comparison, and beside a three-tier dose-escalation chart ($200/$270/$330) footnoted as "illustrative of typical dose-based pricing in the GLP-1 category" rather than attributed to a real competitor. The flat-pricing claim is genuine; the anchors around it are decoration.
Branded vs compounded
Compounded semaglutide and tirzepatide, plus injectable NAD⁺ and injectable glutathione. On the evidence: the GLP-1 outcome data is strong and belongs to the branded products rather than compounded copies, which are not FDA-approved and are not assessed by the FDA for potency, purity or consistency; injectable NAD⁺ is compounded and has no controlled human outcome trials, with the randomized data sitting instead with oral NR and NMN on the endpoint of raising blood NAD⁺; injectable glutathione has essentially no controlled human outcome evidence for the uses it is marketed on. Renlo carries the FDA disclaimer correctly on its longevity pages.
Pros and watch-outs
What we like
- Flat monthly price at every dose, with no membership, consultation or cancellation fee
- Names the provider group (Arora Health & Aesthetics, LLC), the lead physician, the pharmacy (VialsRX) and the 503A basis
- The advertised price is the month-to-month price — no prepay sleight of hand
- LegitScript seal id resolves; all 50 states stated
- Four-month money-back guarantee published, conditioned on following the plan
Watch-outs
- Struck-through $299 / $399 anchors beside every price are never explained
- Its dose-escalation comparison chart is labeled illustrative of the category rather than sourced to a named competitor
- Provider group shared with Solaya MD, The Edit and Trellis Vitality; pharmacy shared with Idgie Health
- Longevity line is NAD⁺ and glutathione only — no sermorelin or repair peptides
Best for
Buyers who want one flat monthly price and the provider group, pharmacy and compounding basis all named before they start.
Who should look elsewhere
Anyone wanting a peptide menu beyond NAD⁺ and glutathione, or who is separately considering Solaya MD, The Edit or Trellis Vitality.
The evidence behind what Renlo Health prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
- Tirzepatide vs semaglutide for weight loss: what the trials actually support
Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.
- NAD injections: how to get them near you or online, and what the evidence really says
Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
How Renlo Health compares
A few alternatives worth a look, depending on what you’re optimizing for.
Idgie HealthOne menu covering GLP-1, NAD⁺, sermorelin and hair care with the pharmacy named
See Idgie Health →
No BS RXReaders who want the month-to-month price first and every plan length beside it
See No BS RX →
Rx.comBuyers who want the pharmacy, the provider network and the boxed warning all published up front
See Rx.com →
More GLP-1 telehealth reviews: FoundyourEraBreeze MedsBodybuilding Health+Synergy RxGala Health
Access & cost · Reviewed and last verified September 2026
How we assessed this. This review reflects Aminoscope’s own read of Renlo Health’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Is $199 a month the real price at Renlo Health?
- Yes. Renlo bills monthly, states no membership fee and no consultation fee, and commits to the same price at every dose — $199 for compounded semaglutide, $269 for tirzepatide, $179 for NAD⁺ and $129 for glutathione. Its advertised figure is the month-to-month figure rather than a prepay rate, which is rarer here than it should be. A $50 first-order code runs sitewide, so the first month is lower than the ongoing price rather than higher.
- What are the crossed-out $299 and $399 prices?
- The site does not say, and that is the problem. Every product page shows the flat price beside a struck-through higher figure — $299 against $199 for semaglutide, $399 against $269 for tirzepatide — with no indication of whether it is a former price, a list price, a competitor's price or a promotional anchor. The flat-pricing commitment beside it is specific and checkable; the crossed-out number is not, so we would read the $199 as the price and the $299 as decoration.
- Who prescribes and who dispenses at Renlo Health?
- Both are named, which is unusual. The provider group is Arora Health & Aesthetics, LLC, with medical care stated as led by Dr. Sean Arora, and the partner pharmacy is VialsRX, compounding under Section 503A. ⚠ Worth knowing before you compare services: Arora Health & Aesthetics is the same medical group behind Solaya MD, The Edit and Trellis Vitality, and VialsRX is the same pharmacy Idgie Health uses. Renlo sets its own catalog and prices, but the clinical and fulfillment layers are shared.
- How does the four-month money-back guarantee work?
- Renlo states that if you follow your plan for four months and do not see progress, you get a full refund. The condition is "follow your plan," which is the part to read carefully — the site does not publish what evidence of adherence is required, who judges it, or how progress is measured. Guarantees of this shape are common in the category and are usually narrower in the terms than in the banner, so we would treat it as a goodwill policy rather than a contractual backstop.
- Is Renlo Health legit?
- Renlo Health is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. Its stated availability: All 50 states (stated). What it publishes up front: Semaglutide $199/mo flat, tirzepatide $269; no membership or consult fee; Arora Health group, VialsRX. It is cash-pay and states it does not bill insurance. It displays a LegitScript certification claim, which we record as a claim and not as a verified fact: LegitScript's public checker is gated and returns the same page for any domain put into it, so no one can reproduce a check from it. Those are the provider's own published claims rather than checks we could run ourselves, so get the ones that matter to you confirmed in writing before you pay.
- Is Renlo Health expensive compared with other GLP-1 telehealth providers?
- Renlo Health publishes a starting figure of $199/mo. Across the 52 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $269 with a median of $179, which puts Renlo Health above the median. The other 31 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.